BIONIK LABORATORIES CORP.: 10-Q filed 2016-03-17

Name: BIONIK LABORATORIES CORP.: 10-Q filed 2016-03-17
Creator: BIONIK LABORATORIES CORP.

What BIONIK LABORATORIES CORP. reported in its quarterly report filed 2016-03-17 (fiscal Q1 2015): 26 published measures, 57 facts as tagged in accession 0001144204-16-088737.

This filing

Form: 10-Q (quarterly report)
Filed: 2016-03-17
Fiscal period: fiscal Q1 2015
Accession: 0001144204-16-088737 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All BIONIK LABORATORIES CORP. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2015-03-31	6,425,636	USD
At 2014-12-31	413,971	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2015-03-31	8,924,381	USD
At 2014-12-31	464,410	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit
At 2015-03-31	-2,498,745	USD
At 2014-12-31	-50,439	USD
At 2014-03-31	-774,626	USD
At 2013-12-31	-710,982	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2015-03-31	6,125,108	USD
At 2014-12-31	209,933	USD
At 2014-03-31	3,482	USD
At 2013-12-31	2,281	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	-7,634,146	USD	90
2014-04-01 to 2014-12-31	-2,464,747	USD	275
2014-01-01 to 2014-03-31	-82,481	USD	90

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2015-03-31	-12,688,128	USD
At 2014-12-31	-5,053,982	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2015-03-31	100,629	USD
At 2014-12-31	77,922	USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	371,637	USD	90
2014-01-01 to 2014-03-31	0	USD	90

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2015-03-31	6,325,007	USD
At 2014-12-31	336,049	USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	179	USD	90
2014-01-01 to 2014-03-31	17,124	USD	90

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2015-03-31	208,787	USD
At 2014-12-31	308,947	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	1,246,817	USD	90
2014-01-01 to 2014-03-31	493,456	USD	90

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	435,671	USD	90
2014-01-01 to 2014-03-31	232,032	USD	90

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2015-03-31	15,839,500	shares
At 2014-12-31	0	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2015-03-31	10,081,394	USD
At 2014-12-31	4,936,456	USD

Accumulated other comprehensive income or loss

Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.

Period	Value	Unit	Days
At 2015-03-31	42,149	USD
At 2014-12-31	17,350	USD

Gross property, plant and equipment

Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.

Period	Value	Unit	Days
At 2015-03-31	143,301	USD
At 2014-12-31	114,472	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2015-03-31	42,672	USD
At 2014-12-31	36,550	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2015-03-31	332,946	USD
At 2014-12-31	155,463	USD

Prepaid expenses and other current assets

Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.

Period	Value	Unit	Days
At 2015-03-31	158,419	USD
At 2014-12-31	81,130	USD

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	-7,609,347	USD	90
2014-01-01 to 2014-03-31	-63,644	USD	90

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	167,747	USD	90
2014-01-01 to 2014-03-31	95,699	USD	90

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	10,412	USD	90
2014-01-01 to 2014-03-31	423	USD	90

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	-6,387,329	USD	90
2014-01-01 to 2014-03-31	410,975	USD	90

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	6,788,988	USD	90
2014-01-01 to 2014-03-31	0	USD	90

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2015-01-01 to 2015-03-31	-71,773	USD	90
2014-01-01 to 2014-03-31	0	USD	90

Inspect the source

Entity: BIONIK LABORATORIES CORP. / CIK 0001508381
Captured: 2026-09-22 19:49 UTC
SEC response SHA-256: 5bb7fb15cbaa342375014f08f1afdc44fc44d4a568725cfe6cc78e258108a4c6

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001508381.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))